**Core Concept**
Dobutamine is a beta-1 selective agonist that primarily acts on cardiac beta-1 receptors, increasing heart rate, contractility, and cardiac output. It also has a mild effect on peripheral vasodilation, leading to a reduction in systemic vascular resistance.

**Why the Correct Answer is Right**
Dobutamine causes vasodilation of arterioles, particularly in the peripheral circulation, which results in decreased peripheral resistance. This effect is due to its action on vascular smooth muscle, although it is not a direct vasodilator. The reduction in peripheral resistance helps maintain cardiac output without significantly increasing afterload, making it useful in cardiogenic shock. It does not act on D1 or D2 receptors, and it actually increases renal perfusion by improving cardiac output and reducing resistance.

**Why Each Wrong Option is Incorrect**
Option B: Dobutamine primarily acts on beta-1 receptors, not D1 or D2 receptors. D1 and D2 are dopamine receptors, not involved in dobutamine's mechanism.
Option C: Dobutamine increases renal perfusion due to improved cardiac output and reduced systemic resistance, not decreases it.
Option D: Dobutamine increases coronary blood flow, especially in ischemic hearts, by enhancing myocardial oxygen supply.

**Clinical Pearl / High-Yield Fact**
Dobutamine is a first-line inotropic agent in acute decompensated heart failure and cardiogenic shock, with a key advantage of reducing afterload through decreased peripheral resistance — a feature that distinguishes it from other inotropes like dopamine.

✓ Correct Answer: A. Dobutamine decreases peripheral resistance